Expanding treatment options for lower limb ischaemia with Diamond-F self-expanding drug-eluting stent
Global Vascular Co., Ltd. is a developer of a drug-eluting stent delivery system for lower limb artery disease, which achieves the world's first cutting-edge endovascular treatment using nanotechnology.
Immunosuppressant/bioabsorbable polymer coating
Thin struts that do not disturb blood flow.
Small diameter 5Fr. catheter
Ergonomic design handle
Towards a future where the simple act of walking is a given, we strive.
How it works
The stent surface is equipped with BIOZONE Coating® technology, a nanotechnology that suppresses thrombus adhesion. By further suppressing the release of harmful nickel ions in the body, this technology allows for endothelialization, the process by which cells integrate with the stent, without inhibiting it, enabling a stent treatment that is gentle on the body.
Global Vascular Co., Ltd.
Keneta BITO, Shunto MAEGAWA
Ichigaya Science and Technology Innovation Center Building 2F, 3-8 Ichigayatamachi, Shinjuku-ku, Tokyo, JAPAN 162-0843
Design and development of medical equipment, research, consulting, etc.
Diamond Medino Capital Inc.